Skip to main content

Advertisement

Table 1 The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n = 360)

From: Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer

Clinico-pathological characteristics Patients, n (%)
Age (≤50/ >50 years) 125(35%)/235(65%)
Size (≤20/ 21-50/ >50 mm) 185(51%)/162(45%)/13(4%)
Grade (I / II / III) 48(13%)/124(34%)/188(52%)
Involved lymph node (-ve/+ve) 206(57%)/154(43%)
ER status (no/yes) 171(47%)/189(53%)
PR status (no/yes) 194(54%)/166(46%)
HER2 status (no/yes) 289(80%)/71(20%)
Triple-negative tumours (no/yes) 240(67%)/120(33%)
Endocrine therapy (no/yes/unknown) 272(76%)/81(22%)/7(2%)
Chemotherapy (no/yes/unknown) 209(58%)/144(40%)/7(2)
Tumour recurrence (no/local/distant/both) 271(75%)/17(5%)/67(19%)/5(1%)
Alive/cancer death/non cancer death 189(53%)/97(27%)/74(21%)